| Videos | Channels | Search |
The pharma stock that's anything but defensive
Think pharma, think defensive right? Think again! Hikma Pharmaceuticals has shot up in Monday trade. Quoted in London, Hikma's lifted its earnings' guidance.
Peter Garnry, Saxo Bank's Head of Equity Strategy, says the generic brands they have are very attractive. The company also benefits from its geographic targets, notably the Middle East.
Peter says this is a growth type investment in a typically defensive sector. He assesses why Hikma is doing so well right now against its competitors.
01:00 minutes
Tags: defensive, earnings, ftse250, hikma, hikma pharmaceuticals, london, middle east, middleeast, owen, owen thomas, pharma, pharmaceuticals, revenue, saxo, saxo tv, saxotv, share, share trading, shares, thomas, trading, trading equity, tradingfloor.com, video